Входя на эту страницу, Вы подтверждаете, что являетесь  медицинским работником.

Status message

Not the entire site translated, but only to "Journal"

Organizational and Methodological Aspects of the Tobacco Addiction Treatment

S.A. Trushchelev
V. Serbsky National Medical Research Centre for Psychiatry and Narcology, Moscow, Russia

SUMMARY
In the review we summarize results of studies of the organizational and methodological aspects of tobacco addiction treatment, data on the prevalence of this phenomenon among the population are examined, and thematically related issues of diagnosis, treatment and prevention are discussed. There are established, that researches are mainly focused on the epidemiology of the phenomenon and the studies of the effectiveness of the use of drugs. There aren’t publications with a high degree of evidence on the use of non-drug methods have been identified. There aren’t descriptions of the original methods of medical prophylaxis of a high degree of evidence. There aren’t results of studies in organizational medical technology. The medical and social aspects of the formation of nicotine addiction in patients with mental disorders is poorly studied. These research areas require more attention and development.

CONTACT: trushchelev.s@serbsky.ru

References: 

1. Kachaeva M.A., Shport S.V., Trushhelyov S.A. Strategicheskie napravleniya deyatel`nosti VOZ po oxrane psixicheskogo zdorov`ya naseleniya // Rossijskij psixiatricheskij zhurnal. – 2017. – № 6. S. 10–23.
2. VOZ predstavlyaet novy`j doklad o global`noj tabachnoj e`pidemii // Vsemirnaya organizaciya zdravooxraneniya [E`lektronny`j resurs]. – URL: https://www.who.int/ru/news-room/detail/26-07-2019-who-launches-new-repo... (data obrashheniya 10.12.2019).
3. Maslennikova G.Ya., Oganov R.G. Medicinskij i social`no-e`konomicheskij ushherb, obuslovlenny`j kureniem tabaka v Rossijskoj Federacii: bolezni sistemy` krovoobrashheniya // Profilakticheskaya medicina. – 2011. – T. 14, № 3. – S. 19–27.
4. Golenkov A.V. Tabakokurenie pri shizofrenii: chastny`j vopros ili global`naya problema? // Narkologiya. – 2010. – T. 9, № 11 (107). – S. 57–64.
5. Global`ny`j opros vzroslogo naseleniya o potreblenii tabaka (GATS). Rossijskaya Federaciya, 2009. – 171 s.
6. Saxarova G.M., Antonov N.S. Okazanie pomoshhi po otkazu ot tabaka v terapevticheskoj praktike: ucheb. posobie. – M., 2010. – 58 s.
7. Mixajlova Yu. V., Lisicyna M.M., Shikina I.B., Zadorkina, T.G. Rasprostranennost` potrebleniya tabaka sredi shkol`nikov Rossii i stran Evropy` // Social`ny`e aspekty` zdorov`ya naseleniya. – 2017. – T. 57, №. 5.
8. Ob oxrane zdorov`ya grazhdan ot vozdejstviya okruzhayushhego tabachnogo dy`ma i posledstvij potrebleniya tabaka // Rossijskij psixiatricheskij zhurnal. – 2017. – № 2. – S. 74–83.
9. Administrativny`e pravonarusheniya, svyazanny`e s narusheniem ustanovlennogo federal`ny`m zakonom zapreta kureniya tabaka // Rossijskij psixiatricheskij zhurnal. – 2017. – № 2. – S. 84–85.
10. Andreeva T.I., Krasovskij T.S. Tabak i zdorov`e. – Kiev, 2004. – 224 s.
11. Trushhelev S.A. Dissertacii po special`nostyam «Psixiatriya» i «Narkologiya», predstavlenny`e k zashhite v 2018 godu // Rossijskij psixiatricheskij zhurnal. – 2018. – № 5. – C. 74–78.
12. Trushhelev S.A. Dissertacii po special`nostyam «psixiatriya» i «narkologiya», predstavlenny`e k zashhite v 2017 g. // Rossijskij psixiatricheskij zhurnal. – 2017. – № 5. – C. 80–82.
13. Xar`kova O. A., Lyashenko A. A. Kliniko-biologicheskij i social`no-psixologicheskij podxody` k izucheniyu tabakokureniya (obzor literatury`) // Vestnik psixoterapii. – 2011. – №. 38. – S. 58–65.
14. Wagena E.J., van der Meer R.M., Ostelo R.J.W.G. et al. Smoking cessation in patients with chronic obstructive pulmonary disease: results form a Cochrane review: Abstracts of 12 World Conference on Tobacco or Health. – Helsinki, 2003. – P. 664.
15. Fagerstrom K.O. The epidemiology of smoking. Health consequences and benefits of cessation // Drugs. – 2002. – No. 62, Suppl. 2. – P. 1–9.
16. Najdenova N.E., Zubareva N.N. Okazanie pomoshhi kuryashhim pacientam v centrax zdorov`ya i kabinetax medicinskoj profilaktiki: metodich. rekomendacii. – Tomsk: SibGMU, 2015. – 36 s.
17. Levshin V.F. Test na motivaciyu k otkazu ot kureniya i ego prakticheskoe primenenie // Voprosy` narkologii. – 2003. – № 6. – S. 48–53.
18. Wen L., Jiang K., Yuan W. et al. Contribution of Variants in CHRNA5/A3/B4Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism // Mol Neurobiol. – 2016. – Vol. 53, No. 1. – P. 472–484.
19. Wang Q., Li S., Pan L. et al. Association between variants in nicotinic acetylcholine receptor genes and smoking cessation in a Chinese rural population // Am J Addict. – 2016. Vol. 25, No. 4. – P. 297–300. – DOI: 10.1111/ajad.12383
20. Robinson J.D., Versace F., Lam C.Y. et al. Cinciripini The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers // Front Psychiatry. – 2013. – Vol. 4. – P. 114. – DOI: 10.3389/fpsyt.2013.00114. eCollection 2013.
21. Speranskaya O.I., Storozheva Z.I., Bochkarev V.K., Kovaleva M.E. Kliniko-geneticheskaya predikciya farmakorezistentnosti u licz s tabachnoj zavisimost`yu // Voprosy` narkologii. – 2017. – № 11. – S. 21–32.
22. Gong L., He C., Yin Y. et al. Nonlinear modulation of interacting between COMT and depression on brain function // Eur Psychiatry. – 2017. – Vol. 45. – P. 6–13. – DOI: 10.1016/j.eurpsy.2017.05.024
23. Slopien R., Rozycka A., Slopien A. et al. The genetic background of climacteric symptoms in women during menopause // Clin ExpObstet Gynecol. – 2016. – Vol. 43, No. 4. – P. 495–499.
24. Cao Y., Lin X., Chen L. et al. The Catechol-O-Methyltransferase and Dopamine Transporter Genes Moderated the Impact of Peer Relationships on Adolescent Depressive Symptoms: A Gene-Gene-Environment Study // J Youth Adolesc. – 2018. – Vol. 47, No. 11. – P. 2468–2480. – DOI: 10.1007/s10964-018-0925-3. Epub 2018 Sep 21.
25. Da Silva B.S., Rovaris D.L., Schuch J.B. et al. Effects of corticotropin-releasing hormonereceptor 1 SNPs on major depressive disorder are influenced by sex and smoking status // J Affect Disord. – 2016. – Vol. 205. – P. 282–288. – DOI: 10.1016/j.jad.2016.08.008
26. Nishizawa D., Kasai S., Hasegawa J., Ikeda K. Associations between the orexin(hypocretin) receptor 2 gene polymorphism Val 308 Ile and nicotine dependence in genome-wide and subsequent association studies // Mol Brain. – 2015. – Vol. 8. – P. 50. – DOI: 10.1186/s13041-015-0142
27. Wang C., Wang Q., Ji B. et al. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases // Front Mol Neurosci. – 2018. – Vol. 11. P. 220. DOI: 10.3389/fnmol.2018.00220. eCollection 2018.
28. MacGregor F., Alexoff D., Shea C. et al. Inhibition of monoamine oxidase B in the brains of smokers // Nature. – 1996. – Vol. 379, No. 6567. – P. 733–736.
29. Lewis A, Miller JH, Lea RA. Monoamine oxidase and tobacco dependence // Neurotoxicology. – 2007. – Vol. 28 (1). – P. 182–195.
30. Mosolov S.N., Egorov A.Yu., Skoromecz T.A., Czukarzi E`.E`., Gorelik A.L., Nary`shkin A.G., Anichkov A.D., Polyakov Yu.I. Nelekarstvenny`e metody` biologicheskoj terapii v psixiatrii // Psixiatriya: nacional`noe rukovodstvo / pod red. N.G. Neznanova, Yu.A. Aleksandrovskogo. – M., 2018. – S. 952–995.
31. Speranskaya OI. Nemedikamentozny`e metody` v lechenii tabachnoj zavisimosti // Narkologiya: nacional`noe rukovodstvo / pod red. N.N. Ivancza, I.P. Anoxinoj, M.A. Vinnikovoj. – 2-e izd. – M., 2016. – S. 281–287.
32. Ziedonis D., Das S., Larkin C. Tobacco use disorder and treatment: new challenges and opportunities // Dialogues Clin Neurosci. – 2017. – Vol. 19, No. 3. – P. 271–280.
33. Denison E., Underland V., Mosdil A., Vist G.E. Cognitive therapies for smoking cessation: a systematic review. – Report 2017. – Oslo: The Norwegian Institute of Public Health, 2017.
34. Silagy C., Lancaster T., Stead L., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation // Cochrane Database Syst Rev. – 2004. – Vol. 3.
35. Hughes J.R., Stead L.F., Lancaster T. Antidepressants for smoking cessation // Cochrane Database Syst Rev. – 2007, Jan 24. – Vol. 1.
36. Rodionov A.V. Sovremenny`e medikamentozny`e metody` lecheniya tabakokureniya // Medicinskij sovet. – 2018. – № 5. – S. 100–103.
37. Suissa K., Larivière J., Eisenberg M.J., Eberg M., Gore G.C., Grad R. et al. Efficacy and Safety of Smoking Cessation Interventions in Patients with Cardiovascular Disease // Circ Cardiovasc Qual Outcomes. – 2017. – Vol. 10, No. 1.
38. Speranskaya O.I., Trushhelyov S.A., Storozheva Z.I. Zavisimost` ot tabakokureniya u bol`ny`x s psixicheskimi rasstrojstvami depressivnogo spektra: kliniko-patogeneticheskie i terapevticheskie aspekty` // Nevrologiya, nejropsixiatriya, psixosomatika. – 2019. – T. 11, № 2. – C. 115–120.
39. Speranskaya O.I., Kachaeva M.A., Trushhelev S.A. Nikotinovaya zavisimost` u bol`ny`x shizofreniej: kliniko-patogeneticheskij aspekt i vliyanie na lechenie // Rossijskij psixiatricheskij zhurnal. – 2018. – № 4. – S. 40–47.
40. Schroeder S.A. Otkaz ot kureniya dolzhen by`t` neot``emlemoj chast`yu lecheniya tyazhely`x psixicheskix rasstrojstv // World Psychiatry. – 2016. – Vol. 15. – P. 175–176. – DOI: 10.1002/wps.20332
41. Federal`noe rukovodstvo po ispol`zovaniyu lekarstvenny`x sredstv (formulyarnaya sistema) / pod red. A.G. Chuchalina, Yu.B. Belousova, V.V. Yasneczova. − 8-e izd., pererab. i dop. − M.: E`xo, 2007 (M.: Shherbinskaya tipografiya). − 1003 s.
42. Kislov A.I., Volkova E.V. Osobennosti rasprostranennosti i kliniki tabakokureniya sredi vrachej terapevticheskogo i xirurgicheskogo profilej // Izvestiya vy`sshix uchebny`x zavedenij. Povolzhskij region. Medicinskie nauki. – 2012. – №. 1.
43. Smoking: harm reduction. Smoking: harm reduction. Public health guideline. – Published: 5 June 2013. nice.org.uk/guidance/ph4.
44. The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update: A U.S. Public Health Service Report // American journal of preventive medicine. – 2008. – Vol. 35, No. 2. – P. 158–176.